# GW406381 In Patients With Peripheral Nerve Injury

> **NCT00279032** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 40 (—)

## Conditions studied

- Hyperalgesia
- Neurodynia
- Pain
- Trauma

## Interventions

- **DRUG:** GW406381

## Key facts

- **NCT ID:** NCT00279032
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 40 (—)
- **Last updated:** 2009-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00279032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00279032, "GW406381 In Patients With Peripheral Nerve Injury". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00279032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*